17-alpha-hydroxyprogesterone and Vulvar Diseases

17-alpha-hydroxyprogesterone has been researched along with Vulvar Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azziz, R; Carmina, E; Dewailly, D; Fruzzetti, F; Ibañez, L; Knochenhauer, ES; Marcondes, JA; Mendonca, BB; Moran, C; Pignatelli, D; Pugeat, M; Rohmer, V; Speiser, PW; Witchel, SF	1

Other Studies

1 other study(ies) available for 17-alpha-hydroxyprogesterone and Vulvar Diseases

Article	Year
21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. American journal of obstetrics and gynecology, 2000, Volume: 183, Issue:6 Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Aging; Child; Child, Preschool; Clitoris; Cohort Studies; Disease Progression; Female; Hirsutism; Humans; Middle Aged; Oligomenorrhea; Prospective Studies; Puberty, Precocious; Retrospective Studies; Vulvar Diseases	2000

Article

Year

21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study.

American journal of obstetrics and gynecology, 2000, Volume: 183, Issue:6

Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Aging; Child; Child, Preschool; Clitoris; Cohort Studies; Disease Progression; Female; Hirsutism; Humans; Middle Aged; Oligomenorrhea; Prospective Studies; Puberty, Precocious; Retrospective Studies; Vulvar Diseases

2000